.2023 .General coronavirus table. html (Access Date: September, 12 : .
Palacios R,Patiño EG,De Oliveira Piorelli R,Conde M,Batista AP,Zeng G .2020 .Double-blind, randomized, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of treating healthcare professionals with the adsorbed COVID-19 (Inactivated) vaccine manufactured by Sinovac - PROFISCOV: a structured summary of a study protocol for a randomised controlled trial. Trials, 10(1) : 853.
Dagan N,Barda N. .2021 .BNT162b2 mRNA COVID-19 vaccine in a nationwide mass vaccination setting. , 10(15) : 1412-1423.
Haas EJ,Angulo FJ,McLaughlin JM,Anis E,Singer SR,Khan F .2021 .Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet, 6736(21) : 00947-8.
Yilmaz E,Ak R,Hökenek NM,Altıntaş MM,Batirel A,Demirhan R .2021 .Characteristics of the healthcare workers infected with the COVID-19 virus after receiving the first dose of coronavirus vaccine. South Clin Istanbul Euras, 10(3) : 241-244.
Sahu AK,Amrithanand VT,Mathew R,Aggarwal P,Nayer J,Bhoi S. COVID .2020 .-19 in health care workers - A systematic review and meta-analysis. Am J Emerg Med, 05(9) : 1727-1731.
Ujjan ID,Devrajani BR,Ghanghro AA,Shah SZA,COVID19-S4):COVID19-S12-S16 SZA .2020 .The clinical and demographical profile of Coronavirus illness: The tale of Tablighi Jamaat and Zaireen in Quarantine / Isolation center at Sukkur and Hyderabad. Pak J Med Sci, 10 : 2829-S4.
Abbas SW,Zareen SF,Saleem S,Tahir AB,Rasheed A,Sajid A .2020 .Comorbidities in fatal cases of sars-cov-2 in rawalpindi/islamabad pakistan. Pak Armed Forces Med, 70(1) : S232-S236.
Yang JY,Parkins MD,Canakis A .2020 .. Among Hospitalized Helth Care Workers in North America. JAMA Netw Open, 10(1) : .
Sharma P,Mishra S,Basu S. .2021 .Breakthrough Infection With Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers in Delhi: A Single-Institution Study. Cureus, 10(10) : .
Bandyopadhyay S,Baticulon RE,Kadhum M,Alser M,Ojuka DK,Badereddin Y .2020 .Infection and mortality of healthcare workers worldwide from COVID-19: a systematic review. -003097, 10(12) : .
Lai X,Wang M,Qin C,Tan L,Ran L,Chen D .2020 .Coronavirus disease 2019 (COVID-2019) infection among health care workers and implications for prevention measures in a tertiary hospital in Wuhan, China. , 10(5) : .
Abou-ElWafa HS,El-Gilany AH,Albadry AA .2021 .Self-reported COVID-19 among physicians: An Egyptian online study during the pandemic. F1000Res, 10 : 785.
Fusco FM,Pisaturo M,Iodice V,Bellopede R,Tambaro O,Parrella G .2020 .-19 among healthcare workers in a specialist infectious diseases setting in Naples, Southern Italy: results of a cross-sectional surveillance study. J Hosp Infect, 06(4) : 596-600.
Chandan S,Khan SR,Deliwala S,Mohan BP,Ramai D,Chandan OC .2022 .Postvaccination SARS-CoV-2 infection among healthcare workers: A systematic review and meta-analysis. J Med Virol, 10(4) : 1428-1441.
Au WY .2022 .Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis. -069989, 10 : .
Amit S,Beni SA,Biber A,Grinberg A,Leshem E,Regev-Yochay G. Postvaccination COVID .2021 .. Israel. Emerg Infect Dis, 10(4) : 1220-1222.
Lin DY,Gu Y,Wheeler B,Young H,Holloway S,Sunny SK .2022 .Effectiveness of Covid-19 vaccines over a 9-month period in North Carolina. N Engl J Med, 10(10) : 933-941.
Whitaker HJ,Tsang RSM,Byford R,Andrews NJ,Sherlock J,Pillai PS .2021 .Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups. J Infect, 12(5) : 675-683.
Mayr FB,Talisa VB,Shaikh O,Yende S,Butt AA .2022 .Effectiveness of homologous or heterologous Covid-19 boosters in veterans. N Engl J Med, 10(14) : 1375-1377.
Alfaleh A,Alkattan A,Alzaher A,Radwan N,Mahmoud N,Alageel A .2022 .Protective duration of ChAdOx1 and BNT162b2 vaccines against SARS-CoV-2 infection. Clin Drug Investig, 10(10) : 799-806.
Fiolet T,Kherabi Y,MacDonald CJ,Ghosn J,Peiffer-Smadja N. Comparing COVID .2021 .-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin Microbiol Infect, 10(2) : 202-221.
Gerhards C,Thiaucourt M,Hetjens M,Haselmann V,Neumaier M,Kittel M. Heterologous M,Based M .2023 .-CoV-2 vaccination strategy appears superior to a homologous vector-based vaccination scheme in German healthcare workers regarding humoral SARS-CoV-2 response indicating a high boosting effect by mRNA vaccines. Vaccines (Basel), 10(3) : 701.